Suchergebnisse - "Dolzhikova, Inna V"

PubPharm (30)

1

New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses

enthalten in: Antiviral research | 2024

von Siniavin, A. | Gushchin, V. | Shastina, N. | +14

2

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1

enthalten in: Vaccines | 2023

von Pochtovyi, A. | Kustova, D. | Siniavin, A. | +13

3

Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine

enthalten in: bioRxiv.org | 2023

von Komissarov, A. | Dolzhikova, I. | Efimov, G. | +8

4

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period

enthalten in: Frontiers in immunology | 2023

von Fomina, D. | Lebedkina, M. | Iliukhina, A. | +13

5

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

enthalten in: Frontiers in immunology | 2023

von Esmagambetov, I. | Ryabova, E. | Derkaev, A. | +15

6

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents : an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

enthalten in: Frontiers in immunology | 2023

von Tukhvatulin, A. | Dolzhikova, I. | Dzharullaeva, A. | +25

7

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

enthalten in: Emerging microbes & infections | 2022

von Tukhvatulin, A. | Gordeychuk, I. | Dolzhikova, I. | +27

8

SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency : A clinical case

enthalten in: Human vaccines & immunotherapeutics | 2022

von Mukhina, O. | Fomina, D. | Parshin, V. | +10

9

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection : A Prospective Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Molodtsov, I. | Kegeles, E. | Mitin, A. | +58

10

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals

enthalten in: Vaccines | 2022

von Lapa, D. | Grousova, D. | Matusali, G. | +19